Northwest Biothrputcs Inc (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 403 | 0 | 350 | 416 | 239 |
| Gross Profit | 403 | 0 | 350 | 416 | 239 |
| Operating Expenses | 12,689 | 10,676 | 10,399 | 12,823 | 19,809 |
| Operating Income | -12,286 | -10,676 | -10,049 | -12,407 | -19,570 |
| Interest Expense | 1,903 | 1,153 | 1,604 | 807 | 1,447 |
| Other Income | -25 | 145,149 | 57,172 | 17,624 | 16,894 |
| Pre-tax Income | -14,214 | 133,320 | 45,519 | 4,410 | -4,123 |
| Net Income Continuous | -14,214 | 133,320 | 45,519 | 4,410 | -4,123 |
| Net Income | $-14,214 | $133,320 | $45,519 | $4,410 | $-4,123 |
| EPS Basic Total Ops | -0.01 | 0.15 | 0.05 | 0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | 0.15 | 0.05 | 0.01 | 0.00 |
| EPS Diluted Total Ops | -0.01 | -0.04 | -0.01 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | 0.14 | 0.04 | 0.00 | 0.00 |
| EBITDA(a) | $-11,317 | $-10,012 | $-9,739 | $-21,861 | $-8,465 |